Eton Pharmaceuticals, Inc. (ETON)

Eton Pharmaceuticals Revenue

Eton Pharmaceuticals had revenue of $17.28M in the quarter ending March 31, 2025, with 116.95% growth. This brings the company's revenue in the last twelve months to $48.33M, up 40.88% year-over-year. In the year 2024, Eton Pharmaceuticals had annual revenue of $39.01M with 23.29% growth.

• Revenue (ttm): $48.33M
• Revenue Growth: +40.88%
• P/S Ratio: 7.59
• Revenue / Employee: $1,558,935
• Employees: 31
• Market Cap: 375.71M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	39.01M	7.37M	23.29%
Dec 31, 2023	31.64M	10.39M	48.90%
Dec 31, 2022	21.25M	-581.00K	-2.66%
Dec 31, 2021	21.83M	21.79M	55,879.49%
Dec 31, 2020	39.00K	-920.00K	-95.93%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.